Orchid Pharma Limited has informed the Exchange regarding a press release dated February 23, 2024, titled "Orchid Pharma's 'Exblifep' receives USFDA approval: A new milestone for India's Pharmaceutical industry".
Orchid Pharma Limited has informed the Exchange regarding a press release dated February 23, 2024, titled "Orchid Pharma's 'Exblifep' receives USFDA approval: A new milestone for India's Pharmaceutical industry".